Toxicogenomics

Toxicogenomics is defined as the study of the structure and function of the genome and its responds to adverse xenobiotic exposure. It is the toxicological subdiscipline of pharmacogenomics, which is broadly defined as the study of inter-individual variations in whole-genome or candidate gene single-nucleotide polymorphism maps, haplotype markers, and alterations in gene expression that might correlate with drug responses.

  • Toxicogenomics in regulatory application
  • SAR/QSAR models
  • Screening tools to predict toxicity & targets
  • Signature/biomarker qualification
  • Bioinformatics and interpretive challenges in toxicogenomics
  • Challenges of conventional toxicology approaches
  • Toxicogenomics as a predictive tool
  • Identifying critical targets or pathways
  • Gene cloning
  • Use of toxicogenomics information directly as a POD

Related Conference of Toxicogenomics

October 07-08, 2019

Frontiers on Advanced Toxicology & Pathology

Paris, France
October 16-17, 2019

Toxicology and Applied Pharmacology

Singapore
April 22-23, 2020 | Florence, Italy

Global Toxicology 2020

Toxicogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in